HLVX

HilleVax (HLVX)

HilleVax Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HLVX

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:HLVX	HilleVax Inc
2024/05/10	05 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HLVX	HilleVax Inc
2024/05/10	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HLVX	HilleVax Inc
2024/05/10	05 : 05	GlobeNewswire Inc.	HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress	NASDAQ:HLVX	HilleVax Inc
2024/03/21	05 : 00	GlobeNewswire Inc.	HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress	NASDAQ:HLVX	HilleVax Inc
2024/02/13	09 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HLVX	HilleVax Inc
2024/02/06	06 : 05	GlobeNewswire Inc.	HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference	NASDAQ:HLVX	HilleVax Inc
2024/02/03	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HLVX	HilleVax Inc
2024/01/27	07 : 00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:HLVX	HilleVax Inc
2024/01/18	21 : 49	Dow Jones News	HilleVax Taps Sean McLoughlin as Chief Operating Officer	NASDAQ:HLVX	HilleVax Inc
2024/01/18	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HLVX	HilleVax Inc
2024/01/18	21 : 00	GlobeNewswire Inc.	HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer	NASDAQ:HLVX	HilleVax Inc
2024/01/08	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HLVX	HilleVax Inc
2024/01/08	21 : 00	GlobeNewswire Inc.	HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China	NASDAQ:HLVX	HilleVax Inc
2024/01/04	08 : 28	GlobeNewswire Inc.	HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:HLVX	HilleVax Inc
2023/12/19	07 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HLVX	HilleVax Inc
2023/12/19	07 : 28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HLVX	HilleVax Inc
2023/12/09	07 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HLVX	HilleVax Inc
2023/12/06	06 : 56	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HLVX	HilleVax Inc
2023/12/06	06 : 53	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HLVX	HilleVax Inc
2023/12/06	06 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HLVX	HilleVax Inc
2023/11/28	11 : 14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HLVX	HilleVax Inc
2023/11/28	11 : 11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HLVX	HilleVax Inc
2023/11/21	06 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HLVX	HilleVax Inc
2023/11/14	07 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HLVX	HilleVax Inc
2023/11/10	06 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HLVX	HilleVax Inc
2023/11/10	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HLVX	HilleVax Inc
2023/11/10	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HLVX	HilleVax Inc
2023/11/10	06 : 05	GlobeNewswire Inc.	HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress	NASDAQ:HLVX	HilleVax Inc
2023/11/02	05 : 48	GlobeNewswire Inc.	HilleVax to Present at Upcoming Investor Conferences	NASDAQ:HLVX	HilleVax Inc